Participant demographics.
Eighty pediatric patients were prospectively accrued from 4 US academic health centers: Indiana University School of Medicine, Texas Children’s Hospital, University of Michigan, and Children’s National Medical Center. This trial was registered at A total of 10 of 80 patients (12.5%) developed SOS. The median day after HCT of SOS onset was 19 (range 9–34, 